GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (FRA:1KA) » Definitions » Future Policy Benefits

GH Research (FRA:1KA) Future Policy Benefits


View and export this data going back to 2021. Start your Free Trial

What is GH Research Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.


GH Research (FRA:1KA) Business Description

Traded in Other Exchanges
Address
28 Baggot Street Lower, Dublin, IRL, D02 NX43
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Its focus is on developing novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.